Loading…

Clinical Differences between Benign and Malignant Pheochromocytomas

Most pheochromocytomas can be cured by resection. In view of the unfavourable prognosis for surgical therapy in cases of late tumour detection and alignant tumours, the aim of the present study is to differentiate between typical signs and symptoms of malignant versus benign pheochromocytomas. We in...

Full description

Saved in:
Bibliographic Details
Published in:ENDOCRINE JOURNAL 2001, Vol.48(2), pp.151-159
Main Authors: GLODNY, BERNHARD, WINDE, GÜNTHER, HERWIG, RALF, MEIER, ANTJE, KÜHLE, CHRISTIANE, CROMME, STEPHANIE, VETTER, HANS
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c650t-e1ec87d7e349861ebc7e28d78e2bc545f58c89be24047d6bf3ad090d6fdf79083
cites
container_end_page 159
container_issue 2
container_start_page 151
container_title ENDOCRINE JOURNAL
container_volume 48
creator GLODNY, BERNHARD
WINDE, GÜNTHER
HERWIG, RALF
MEIER, ANTJE
KÜHLE, CHRISTIANE
CROMME, STEPHANIE
VETTER, HANS
description Most pheochromocytomas can be cured by resection. In view of the unfavourable prognosis for surgical therapy in cases of late tumour detection and alignant tumours, the aim of the present study is to differentiate between typical signs and symptoms of malignant versus benign pheochromocytomas. We investigated the records of 133 patients retrospectively (1967-1998). In cases of benign tumours (104 of 133, mean age 42± 15.8 years) tumour size was 5.9±3.4cm, and history was 47.4±75.4 months. 7.7% of the tumours were extraadrenal, and 77% had paroxysmal manifestations. The other 29 patients (mean age: 39.2±21.9 years) had malignant lesions (tumour size: 9.4±5.9cm (p=0.0022); history: 7.4±5.6 months (p=0.0137); extraadrenal: 24.1% (p=0.0219); paroxysmal: 37.9% (p=0.0012)). Symptoms of patients with benign tumours were hypertension (80%), headaches (42.3%), sweating (30.8%), tachycardia (26%) and pallor (24% (Malignant: Hypertension 46%, p=0.0873; headaches 11%, p=0.0008; sweating 11%, p=0.0196; tachycardia 14%, p=0.1961 and pallor 0%, p=0.0010)). Abdominal pain and dorsalgia occurred more frequently in malignant pheochromocytomas (26% versus 7%, p=0.0014). Unusually short histories and extraadrenal localization appear to be suspicious for malignancy. The “typical” clinical signs and symptoms occur more frequently in patients with benign tumours and can therefore be regarded as typical signs of benign pheochromocytomas.
doi_str_mv 10.1507/endocrj.48.151
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71011031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71011031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c650t-e1ec87d7e349861ebc7e28d78e2bc545f58c89be24047d6bf3ad090d6fdf79083</originalsourceid><addsrcrecordid>eNpFkE1v1DAQhi1ERZe2V44oJ25ZxrEd20fYQkFqBQc4W4496WaV2K2dFeq_x-mmcJkP-ZnXMy8h7yhsqQD5EYOPLh22XJWeviIbyriqueDwmmxAU1UrLfQ5eZvzAYAxwdkbck4pF23T0g3Z7cYhDM6O1fXQ95gwOMxVh_MfxFB9xjDch8oGX93ZsZQ2zNXPPUa3T3GK7mmOk82X5Ky3Y8arNV-Q31-__Np9q29_3HzffbqtXStgrpGiU9JLZFyrlmLnJDbKS4VN5wQXvVBO6Q4bDlz6tuuZ9aDBt73vpQbFLsiHk-5Dio9HzLOZhuxwHG3AeMxGUqAUGC3g9gS6FHNO2JuHNEw2PRkKZrHNrLYZrkq_DLxflY_dhP4_vvpUgJsTUF4Xt2IotqE5xGMK5WTjHttnSdMAUAPAFTQlCQNFfgmagpDy-YhV6ZBne4__vrJpHtyIL5tRrdmyXXMKi8oL4fY2FYz9BZi2mkY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71011031</pqid></control><display><type>article</type><title>Clinical Differences between Benign and Malignant Pheochromocytomas</title><source>JSTAGE</source><creator>GLODNY, BERNHARD ; WINDE, GÜNTHER ; HERWIG, RALF ; MEIER, ANTJE ; KÜHLE, CHRISTIANE ; CROMME, STEPHANIE ; VETTER, HANS</creator><creatorcontrib>GLODNY, BERNHARD ; WINDE, GÜNTHER ; HERWIG, RALF ; MEIER, ANTJE ; KÜHLE, CHRISTIANE ; CROMME, STEPHANIE ; VETTER, HANS ; Rheinische Friedrich-Wilhelms-University Bonn ; thoracic and visceral surgery ; Institute of Pharmaceutical Biology and Phytochemistry ; Medical Policlinic ; Department of Surgery(general ; Hospital Herford ; Westfalische Wilhelms-Universitat Munster ; Department of Urology</creatorcontrib><description>Most pheochromocytomas can be cured by resection. In view of the unfavourable prognosis for surgical therapy in cases of late tumour detection and alignant tumours, the aim of the present study is to differentiate between typical signs and symptoms of malignant versus benign pheochromocytomas. We investigated the records of 133 patients retrospectively (1967-1998). In cases of benign tumours (104 of 133, mean age 42± 15.8 years) tumour size was 5.9±3.4cm, and history was 47.4±75.4 months. 7.7% of the tumours were extraadrenal, and 77% had paroxysmal manifestations. The other 29 patients (mean age: 39.2±21.9 years) had malignant lesions (tumour size: 9.4±5.9cm (p=0.0022); history: 7.4±5.6 months (p=0.0137); extraadrenal: 24.1% (p=0.0219); paroxysmal: 37.9% (p=0.0012)). Symptoms of patients with benign tumours were hypertension (80%), headaches (42.3%), sweating (30.8%), tachycardia (26%) and pallor (24% (Malignant: Hypertension 46%, p=0.0873; headaches 11%, p=0.0008; sweating 11%, p=0.0196; tachycardia 14%, p=0.1961 and pallor 0%, p=0.0010)). Abdominal pain and dorsalgia occurred more frequently in malignant pheochromocytomas (26% versus 7%, p=0.0014). Unusually short histories and extraadrenal localization appear to be suspicious for malignancy. The “typical” clinical signs and symptoms occur more frequently in patients with benign tumours and can therefore be regarded as typical signs of benign pheochromocytomas.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.48.151</identifier><identifier>PMID: 11456261</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Abdominal Pain ; Adolescent ; Adrenal Gland Neoplasms - diagnosis ; Adrenal Gland Neoplasms - pathology ; Adrenal Gland Neoplasms - surgery ; Adult ; Aged ; Back Pain ; Catecholamines - metabolism ; Child ; Child, Preschool ; Diagnosis ; Diagnosis, Differential ; Female ; Headache ; Humans ; Hypertension ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Pallor ; Pheochromocytoma ; Pheochromocytoma - diagnosis ; Pheochromocytoma - pathology ; Pheochromocytoma - surgery ; Prognosis ; Retrospective Studies ; Surgical therapy ; Sweating ; Symptoms ; Tachycardia ; Weight Loss</subject><ispartof>Endocrine Journal, 2001, Vol.48(2), pp.151-159</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c650t-e1ec87d7e349861ebc7e28d78e2bc545f58c89be24047d6bf3ad090d6fdf79083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1882,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11456261$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GLODNY, BERNHARD</creatorcontrib><creatorcontrib>WINDE, GÜNTHER</creatorcontrib><creatorcontrib>HERWIG, RALF</creatorcontrib><creatorcontrib>MEIER, ANTJE</creatorcontrib><creatorcontrib>KÜHLE, CHRISTIANE</creatorcontrib><creatorcontrib>CROMME, STEPHANIE</creatorcontrib><creatorcontrib>VETTER, HANS</creatorcontrib><creatorcontrib>Rheinische Friedrich-Wilhelms-University Bonn</creatorcontrib><creatorcontrib>thoracic and visceral surgery</creatorcontrib><creatorcontrib>Institute of Pharmaceutical Biology and Phytochemistry</creatorcontrib><creatorcontrib>Medical Policlinic</creatorcontrib><creatorcontrib>Department of Surgery(general</creatorcontrib><creatorcontrib>Hospital Herford</creatorcontrib><creatorcontrib>Westfalische Wilhelms-Universitat Munster</creatorcontrib><creatorcontrib>Department of Urology</creatorcontrib><title>Clinical Differences between Benign and Malignant Pheochromocytomas</title><title>ENDOCRINE JOURNAL</title><addtitle>Endocr J</addtitle><description>Most pheochromocytomas can be cured by resection. In view of the unfavourable prognosis for surgical therapy in cases of late tumour detection and alignant tumours, the aim of the present study is to differentiate between typical signs and symptoms of malignant versus benign pheochromocytomas. We investigated the records of 133 patients retrospectively (1967-1998). In cases of benign tumours (104 of 133, mean age 42± 15.8 years) tumour size was 5.9±3.4cm, and history was 47.4±75.4 months. 7.7% of the tumours were extraadrenal, and 77% had paroxysmal manifestations. The other 29 patients (mean age: 39.2±21.9 years) had malignant lesions (tumour size: 9.4±5.9cm (p=0.0022); history: 7.4±5.6 months (p=0.0137); extraadrenal: 24.1% (p=0.0219); paroxysmal: 37.9% (p=0.0012)). Symptoms of patients with benign tumours were hypertension (80%), headaches (42.3%), sweating (30.8%), tachycardia (26%) and pallor (24% (Malignant: Hypertension 46%, p=0.0873; headaches 11%, p=0.0008; sweating 11%, p=0.0196; tachycardia 14%, p=0.1961 and pallor 0%, p=0.0010)). Abdominal pain and dorsalgia occurred more frequently in malignant pheochromocytomas (26% versus 7%, p=0.0014). Unusually short histories and extraadrenal localization appear to be suspicious for malignancy. The “typical” clinical signs and symptoms occur more frequently in patients with benign tumours and can therefore be regarded as typical signs of benign pheochromocytomas.</description><subject>Abdominal Pain</subject><subject>Adolescent</subject><subject>Adrenal Gland Neoplasms - diagnosis</subject><subject>Adrenal Gland Neoplasms - pathology</subject><subject>Adrenal Gland Neoplasms - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Back Pain</subject><subject>Catecholamines - metabolism</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Diagnosis</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Headache</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>Pallor</subject><subject>Pheochromocytoma</subject><subject>Pheochromocytoma - diagnosis</subject><subject>Pheochromocytoma - pathology</subject><subject>Pheochromocytoma - surgery</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Surgical therapy</subject><subject>Sweating</subject><subject>Symptoms</subject><subject>Tachycardia</subject><subject>Weight Loss</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkE1v1DAQhi1ERZe2V44oJ25ZxrEd20fYQkFqBQc4W4496WaV2K2dFeq_x-mmcJkP-ZnXMy8h7yhsqQD5EYOPLh22XJWeviIbyriqueDwmmxAU1UrLfQ5eZvzAYAxwdkbck4pF23T0g3Z7cYhDM6O1fXQ95gwOMxVh_MfxFB9xjDch8oGX93ZsZQ2zNXPPUa3T3GK7mmOk82X5Ky3Y8arNV-Q31-__Np9q29_3HzffbqtXStgrpGiU9JLZFyrlmLnJDbKS4VN5wQXvVBO6Q4bDlz6tuuZ9aDBt73vpQbFLsiHk-5Dio9HzLOZhuxwHG3AeMxGUqAUGC3g9gS6FHNO2JuHNEw2PRkKZrHNrLYZrkq_DLxflY_dhP4_vvpUgJsTUF4Xt2IotqE5xGMK5WTjHttnSdMAUAPAFTQlCQNFfgmagpDy-YhV6ZBne4__vrJpHtyIL5tRrdmyXXMKi8oL4fY2FYz9BZi2mkY</recordid><startdate>2001</startdate><enddate>2001</enddate><creator>GLODNY, BERNHARD</creator><creator>WINDE, GÜNTHER</creator><creator>HERWIG, RALF</creator><creator>MEIER, ANTJE</creator><creator>KÜHLE, CHRISTIANE</creator><creator>CROMME, STEPHANIE</creator><creator>VETTER, HANS</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2001</creationdate><title>Clinical Differences between Benign and Malignant Pheochromocytomas</title><author>GLODNY, BERNHARD ; WINDE, GÜNTHER ; HERWIG, RALF ; MEIER, ANTJE ; KÜHLE, CHRISTIANE ; CROMME, STEPHANIE ; VETTER, HANS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c650t-e1ec87d7e349861ebc7e28d78e2bc545f58c89be24047d6bf3ad090d6fdf79083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Abdominal Pain</topic><topic>Adolescent</topic><topic>Adrenal Gland Neoplasms - diagnosis</topic><topic>Adrenal Gland Neoplasms - pathology</topic><topic>Adrenal Gland Neoplasms - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Back Pain</topic><topic>Catecholamines - metabolism</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Diagnosis</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Headache</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>Pallor</topic><topic>Pheochromocytoma</topic><topic>Pheochromocytoma - diagnosis</topic><topic>Pheochromocytoma - pathology</topic><topic>Pheochromocytoma - surgery</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Surgical therapy</topic><topic>Sweating</topic><topic>Symptoms</topic><topic>Tachycardia</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GLODNY, BERNHARD</creatorcontrib><creatorcontrib>WINDE, GÜNTHER</creatorcontrib><creatorcontrib>HERWIG, RALF</creatorcontrib><creatorcontrib>MEIER, ANTJE</creatorcontrib><creatorcontrib>KÜHLE, CHRISTIANE</creatorcontrib><creatorcontrib>CROMME, STEPHANIE</creatorcontrib><creatorcontrib>VETTER, HANS</creatorcontrib><creatorcontrib>Rheinische Friedrich-Wilhelms-University Bonn</creatorcontrib><creatorcontrib>thoracic and visceral surgery</creatorcontrib><creatorcontrib>Institute of Pharmaceutical Biology and Phytochemistry</creatorcontrib><creatorcontrib>Medical Policlinic</creatorcontrib><creatorcontrib>Department of Surgery(general</creatorcontrib><creatorcontrib>Hospital Herford</creatorcontrib><creatorcontrib>Westfalische Wilhelms-Universitat Munster</creatorcontrib><creatorcontrib>Department of Urology</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ENDOCRINE JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GLODNY, BERNHARD</au><au>WINDE, GÜNTHER</au><au>HERWIG, RALF</au><au>MEIER, ANTJE</au><au>KÜHLE, CHRISTIANE</au><au>CROMME, STEPHANIE</au><au>VETTER, HANS</au><aucorp>Rheinische Friedrich-Wilhelms-University Bonn</aucorp><aucorp>thoracic and visceral surgery</aucorp><aucorp>Institute of Pharmaceutical Biology and Phytochemistry</aucorp><aucorp>Medical Policlinic</aucorp><aucorp>Department of Surgery(general</aucorp><aucorp>Hospital Herford</aucorp><aucorp>Westfalische Wilhelms-Universitat Munster</aucorp><aucorp>Department of Urology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Differences between Benign and Malignant Pheochromocytomas</atitle><jtitle>ENDOCRINE JOURNAL</jtitle><addtitle>Endocr J</addtitle><date>2001</date><risdate>2001</risdate><volume>48</volume><issue>2</issue><spage>151</spage><epage>159</epage><pages>151-159</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>Most pheochromocytomas can be cured by resection. In view of the unfavourable prognosis for surgical therapy in cases of late tumour detection and alignant tumours, the aim of the present study is to differentiate between typical signs and symptoms of malignant versus benign pheochromocytomas. We investigated the records of 133 patients retrospectively (1967-1998). In cases of benign tumours (104 of 133, mean age 42± 15.8 years) tumour size was 5.9±3.4cm, and history was 47.4±75.4 months. 7.7% of the tumours were extraadrenal, and 77% had paroxysmal manifestations. The other 29 patients (mean age: 39.2±21.9 years) had malignant lesions (tumour size: 9.4±5.9cm (p=0.0022); history: 7.4±5.6 months (p=0.0137); extraadrenal: 24.1% (p=0.0219); paroxysmal: 37.9% (p=0.0012)). Symptoms of patients with benign tumours were hypertension (80%), headaches (42.3%), sweating (30.8%), tachycardia (26%) and pallor (24% (Malignant: Hypertension 46%, p=0.0873; headaches 11%, p=0.0008; sweating 11%, p=0.0196; tachycardia 14%, p=0.1961 and pallor 0%, p=0.0010)). Abdominal pain and dorsalgia occurred more frequently in malignant pheochromocytomas (26% versus 7%, p=0.0014). Unusually short histories and extraadrenal localization appear to be suspicious for malignancy. The “typical” clinical signs and symptoms occur more frequently in patients with benign tumours and can therefore be regarded as typical signs of benign pheochromocytomas.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>11456261</pmid><doi>10.1507/endocrj.48.151</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 2001, Vol.48(2), pp.151-159
issn 0918-8959
1348-4540
language eng
recordid cdi_proquest_miscellaneous_71011031
source JSTAGE
subjects Abdominal Pain
Adolescent
Adrenal Gland Neoplasms - diagnosis
Adrenal Gland Neoplasms - pathology
Adrenal Gland Neoplasms - surgery
Adult
Aged
Back Pain
Catecholamines - metabolism
Child
Child, Preschool
Diagnosis
Diagnosis, Differential
Female
Headache
Humans
Hypertension
Male
Middle Aged
Neoplasm Invasiveness
Neoplasm Metastasis
Pallor
Pheochromocytoma
Pheochromocytoma - diagnosis
Pheochromocytoma - pathology
Pheochromocytoma - surgery
Prognosis
Retrospective Studies
Surgical therapy
Sweating
Symptoms
Tachycardia
Weight Loss
title Clinical Differences between Benign and Malignant Pheochromocytomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A02%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Differences%20between%20Benign%20and%20Malignant%20Pheochromocytomas&rft.jtitle=ENDOCRINE%20JOURNAL&rft.au=GLODNY,%20BERNHARD&rft.aucorp=Rheinische%20Friedrich-Wilhelms-University%20Bonn&rft.date=2001&rft.volume=48&rft.issue=2&rft.spage=151&rft.epage=159&rft.pages=151-159&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.48.151&rft_dat=%3Cproquest_cross%3E71011031%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c650t-e1ec87d7e349861ebc7e28d78e2bc545f58c89be24047d6bf3ad090d6fdf79083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71011031&rft_id=info:pmid/11456261&rfr_iscdi=true